ModelEdge

Scinai Immunotherapeutics Ltd
SCNI
Filing Type20-F
Filing Date5/6/2025
Updated5/7/25, 5:42 AM

Filing

20-F
Earnings Release

Exhibits

20-FAnnual and Transition Report of Foreign Private Issuers
EX-1.1ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTD
EX-2.3DESCRIPTION OF SHARE CAPITAL
EX-4.3COMPENSATION POLICY
EX-4.15AMENDMENT NO. 1 TO LEASE AGREEMENT, DATED APRIL 29, 2022 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)
EX-4.16AMENDMENT NO. 2 TO LEASE AGREEMENT, DATED JUNE 3, 2023 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)
EX-4.17AMENDMENT NO. 3 TO LEASE AGREEMENT, DATED JULY 10, 2023 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)
EX-4.18AMENDMENT NO. 4 TO LEASE AGREEMENT, DATED DECEMBER 15, 2024 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)
EX-4.19AMENDMENT NO. 5 TO LEASE AGREEMENT, DATED DECEMBER 24, 2024. (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)
EX-4.29BINDING OPTION AGREEMENT CONCERNING THE SALE AND TRANSFER OF ALL QUOTA IN PINCELL S.R.L. BETWEEN MR. CARLO PINCELLI, MR. ANTONINO AMATO, MRS. ALESSANDRA MARCONI, MRS. ROBERTA LOTTI, MR. BRYDON BENNETT, MS. STEFANIA POLI, PINCELL S.R.L.
EX-8.1LIST OF SUBSIDIARIES OF THE COMPANY
EX-11.2INSIDER TRADING POLICY
EX-12.1CERTIFICATION
EX-12.2CERTIFICATION
EX-13.1CERTIFICATION
EX-13.2CERTIFICATION
EX-15.1CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANT
EX-15.2CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANT
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic